The Cannabis Advisory

CBD News

nabiximols

STUDY: Multiple Sclerosis – Sativex-induced neurobehavioral effects: causal or concausal? A practical advice!

Written By

ABSTRACT: Nabiximols (Sativex) is an oromucosal spray, containing delta-9 tetrahydrocannabinol (THC) and cannabidiol (CBD), used as treatment for unresponsive spasticity in multiple sclerosis (MS) patients. Sativex is thought to not affect cognition or induce any psychiatric problem at the doses generally used. Nonetheless, it is known that the concomitant use of more than one ... Continue Reading

STUDY: Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity

Written By

ABSTRACT: A large proportion of patients with multiple sclerosis (MS) have spasticity, which has a marked impact on their quality of life. Anecdotal evidence suggests a beneficial effect of cannabis on spasticity as well as pain. Recently, randomized, double-blind, placebo-controlled studies have confirmed the clinical efficacy of cannabinoids for the treatment of spasticity ... Continue Reading

Contributing Authors